Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
The pressure is building for employers, insurers, and Medicare to pay for costly weight-loss drugs. But many health plans aren't yielding and some...
Read MoreShortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The long-running U.S. shortage of Novo Nordisk's blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than...
Read More
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Read More
Novo Nordisk reports positive next-generation obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday.
Read More
Weight-loss jabs like Wegovy linked to dozens of UK deaths - here are the facts
Some health experts have call for further investigation, as figures show 82 deaths with suspected links to slimming drugs since 2019
Read MoreThe Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.
Read MoreEnd of content
No more pages to load